The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Long-term follow-up of patterns of melanoma early and late recurrence after adjuvant anti-PD1 therapy.
 
Christy Jesme
No Relationships to Disclose
 
John Marsiglio
No Relationships to Disclose
 
Feng Bingjian
No Relationships to Disclose
 
Magdalena Kovacsovics
No Relationships to Disclose
 
Berit Gibson
No Relationships to Disclose
 
Qin Zhou
No Relationships to Disclose
 
Umang Swami
Consulting or Advisory Role - Adaptimmune; Astellas Pharma; AstraZeneca; Exelixis; Gilead Sciences; Imvax; Janssen Scientific Affairs; Pfizer; Sanofi; Seagen
Research Funding - Exelixis (Inst); Janssen (Inst); lava therapeutics (Inst); Loxo/Lilly (Inst); Merck (Inst); ORIC Pharmaceuticals (Inst); Seagen (Inst); Seattle Genetics/Astellas (Inst)
 
Jeffery Russell
No Relationships to Disclose
 
Alyssa Erickson-Wayman
No Relationships to Disclose
 
Elliot Asare
No Relationships to Disclose
 
Marcus Monroe
No Relationships to Disclose
 
Tawnya Bowles
No Relationships to Disclose
 
Aikchoon Tan
Employment - Bristol-Myers Squibb/Celgene/Juno (I)
Stock and Other Ownership Interests - Bristol-Myers Squibb/Celgene/Juno (I)
 
John Hyngstrom
No Relationships to Disclose
 
Siwen Hu-Lieskovan
Consulting or Advisory Role - Amgen; Cardinal Health; Delcath Systems; Endeavor BioMedicines; Immunocore; Replimune